论文部分内容阅读
一般认为糖尿病患者并发尿路感染的治疗方案与非糖尿病患者相同。本文评价用小剂量磺胺甲基异(口中恶)唑(SMZ)-三甲氧基苄氨嘧啶(TMP)合剂(简称 ST合剂)长期治疗糖尿病持续性或复发性尿路感染的作用。研究对象为糖尿病并发尿路感染患者96例(男25,女71),其中有症状者38例,无症状性细菌尿者58例。患者以高龄者为主,60岁以上57例。93例曾作肾盂造影检查,其中36例膀胱内可见残余尿,包括5例糖尿病性神经膀胱,16例前列腺肥大,2例肾结石和1例
Diabetes is generally considered the treatment of urinary tract infection and non-diabetic patients with the same treatment. This article evaluates the long-term treatment of persistent or recurrent urinary tract infections with diabetes with a small dose of the sulfamethoxazole (SMZ) -trimethoxybenzamidine (TMP) cocktail (abbreviated as ST). The subjects of study were 96 patients with diabetes (urinary tract infection) (male 25, female 71), of whom 38 had symptoms and 58 had asymptomatic bacterial urine. Elderly patients mainly in 57 cases over the age of 60. 93 cases had pyelography, including 36 cases of residual urine visible in the bladder, including 5 cases of diabetic neurogenic bladder, 16 cases of prostatic hypertrophy, 2 cases of kidney stones and 1 case